What is the prevalence of human papillomavirus (HPV) infection in vaginal and vulvar neoplasias and cancers? What proportion of these diseases might be prevented by the quadrivalent HPV vaccine?

High-risk (oncogenic) HPV types, such as 16, 18, 61 and 73 were more likely to persist than nononcogenic types; however, the majority of high-risk HPV infections were cleared within 24 months.

Safer vaccine The next generation of polio vaccinations is likely to be produced in yeast or insect cells. Our research shows that VLPs produced in both yeast and insect cells can perform equally ...

Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines. Nature Communications, 2025; 16 (1) DOI: 10.1038/s41467-025-56118-z ...

Oral polio vaccine (OPV), which contains live but weakened vaccine-virus, is also used in vaccination against polio. Future polio vaccines However, once all remaining strains of wild poliovirus have ...

Since 2006, the HPV vaccine has been recommended for young females ages 11 or 12 but may be available for some children as early as age 9. The same recommendation for young males followed in 2011.

The first ever HPV vaccine — Gardasil — was put on the market in 2006. Increasing vaccination rates have since worked to steadily knock down cases of the disease along with increased screening ...

Each year, HPV causes approximately 36,000 cases of cancer in men and women, CDC said. can help prevent cancer, and the vaccine aims to stop cancer before it can metastasize.

HPV can cause several types of genital cancer, including cervical cancer, penile cancer, anal cancer and vaginal cancer. “I think there’s some well-intentioned parents who maybe are worried that ...

The HPV vaccine has been around for about 20 years and over time has been improved to cover more varieties of HPV. The vaccine’s main side effect has been irritation or redness around the area where ...